A detailed history of Engineers Gate Manager LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 29,732 shares of ARVN stock, worth $768,869. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,732
Previous 54,759 45.7%
Holding current value
$768,869
Previous $1.46 Million 49.76%
% of portfolio
0.02%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.66 - $32.73 $592,138 - $819,133
-25,027 Reduced 45.7%
29,732 $732,000
Q2 2024

Aug 14, 2024

BUY
$24.46 - $40.4 $132,940 - $219,574
5,435 Added 11.02%
54,759 $1.46 Million
Q1 2024

May 15, 2024

BUY
$36.38 - $52.31 $1.4 Million - $2.02 Million
38,560 Added 358.23%
49,324 $2.04 Million
Q4 2023

Feb 14, 2024

SELL
$14.19 - $42.33 $71,602 - $213,597
-5,046 Reduced 31.92%
10,764 $443,000
Q3 2023

Nov 14, 2023

SELL
$19.64 - $28.21 $135,417 - $194,507
-6,895 Reduced 30.37%
15,810 $310,000
Q2 2023

Aug 14, 2023

SELL
$21.73 - $31.43 $391,422 - $566,148
-18,013 Reduced 44.24%
22,705 $563,000
Q1 2023

May 15, 2023

BUY
$26.15 - $37.26 $515,390 - $734,357
19,709 Added 93.81%
40,718 $1.11 Million
Q4 2022

Feb 14, 2023

BUY
$32.47 - $57.24 $219,951 - $387,743
6,774 Added 47.59%
21,009 $718,000
Q3 2022

Nov 14, 2022

BUY
$41.87 - $57.99 $596,019 - $825,487
14,235 New
14,235 $633,000
Q2 2022

Aug 15, 2022

SELL
$36.01 - $74.24 $272,055 - $560,883
-7,555 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$60.27 - $81.57 $69,250 - $93,723
1,149 Added 17.94%
7,555 $508,000
Q4 2021

Feb 14, 2022

SELL
$65.85 - $96.21 $467,534 - $683,091
-7,100 Reduced 52.57%
6,406 $526,000
Q3 2021

Nov 15, 2021

SELL
$73.2 - $107.87 $634,204 - $934,585
-8,664 Reduced 39.08%
13,506 $1.11 Million
Q2 2021

Aug 16, 2021

BUY
$60.45 - $84.26 $639,561 - $891,470
10,580 Added 91.29%
22,170 $1.71 Million
Q1 2021

May 17, 2021

SELL
$58.19 - $91.37 $2.32 Million - $3.64 Million
-39,878 Reduced 77.48%
11,590 $766,000
Q4 2020

Feb 16, 2021

SELL
$20.19 - $84.93 $729,081 - $3.07 Million
-36,111 Reduced 41.23%
51,468 $4.37 Million
Q3 2020

Nov 16, 2020

BUY
$22.99 - $36.34 $303,881 - $480,342
13,218 Added 17.78%
87,579 $2.07 Million
Q2 2020

Aug 17, 2020

BUY
$29.88 - $56.74 $1.29 Million - $2.44 Million
43,045 Added 137.45%
74,361 $2.49 Million
Q1 2020

May 15, 2020

SELL
$33.0 - $54.5 $996,831 - $1.65 Million
-30,207 Reduced 49.1%
31,316 $1.26 Million
Q4 2019

Feb 14, 2020

BUY
$15.39 - $44.38 $408,465 - $1.18 Million
26,541 Added 75.87%
61,523 $2.53 Million
Q3 2019

Nov 14, 2019

BUY
$21.55 - $27.61 $147,660 - $189,183
6,852 Added 24.36%
34,982 $754,000
Q2 2019

Aug 14, 2019

BUY
$15.96 - $23.8 $448,954 - $669,494
28,130 New
28,130 $619,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.38B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.